Twist Bioscience (NASDAQ:TWST) reported quarterly losses of $(0.59) per share which missed the analyst consensus estimate of $(0.48) by 22.92 percent. This is a 10.61 percent increase over losses of $(0.66) per share from the same period last year. The company reported quarterly sales of $110.715 million which beat the analyst consensus estimate of $107.657 million by 2.84 percent. This is a 19.31 percent increase over sales of $92.793 million the same period last year.